VORICONAZOLE (O.S)

Overview

Monitoring trough levels of voriconazole is suggested in individuals with reduced liver function, individuals with cytochrome P450 (CYP) 2C19 alterations associated with poor metabolic function, patients taking other medications that affect CYP2C19 activity, and in patients experiencing potential toxicity Monitoring trough levels may be reasonable in patients who are not responding optimally or have drug interactions that may decrease voriconazole levels, or to ensure adequate oral absorption.